Roivant Sciences (ROIV) Other Non-Current Assets (2021 - 2026)

Roivant Sciences (ROIV) reported Other Non-Current Assets of $40.9 million for Q1 2026, up 24.52% on a YoY basis from $32.9 million in Q1 2025, and up 18.38% quarter-over-quarter from $34.6 million in Q4 2025.

Roivant Sciences (ROIV) Other Non-Current Assets (2021 - 2026) Analysis & Trends

Roivant Sciences has reported Other Non-Current Assets for 6 years, with the latest figure at $40.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets rose 24.52% year-over-year to $40.9 million; the trailing twelve-month figure through Mar 2026 stood at $40.9 million (up 24.52% YoY), and the FY2026 full-year result was $40.9 million, up 24.52% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $40.9 million, up from $34.6 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $320.2 million in Q3 2024, with the low at $9.6 million in Q3 2022.
  • Historically, Other Non-Current Assets has averaged $60.1 million across 5 years, with a median of $37.7 million in 2025.
  • Annual changes were most pronounced in 2024 — Other Non-Current Assets surged 543.1% — and 2025, when it plunged 91.31%.
  • Roivant Sciences' Other Non-Current Assets stood at $46.2 million in 2022, then grew by 1.35% to $46.8 million in 2023, then soared by 583.56% to $320.2 million in 2024, then slumped by 89.21% to $34.6 million in 2025, then increased by 18.38% to $40.9 million in 2026.
  • The last three Other Non-Current Assets figures came in at $40.9 million (Q1 2026), $34.6 million (Q4 2025), and $27.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 12.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 60,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.26 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Roivant Sciences 21.82 Bn 22.59 Bn - 40.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 40.92 Mn
Dec 31, 2025 34.56 Mn
Sep 30, 2025 27.83 Mn
Jun 30, 2025 31.09 Mn
Mar 31, 2025 32.86 Mn
Sep 30, 2024 320.24 Mn
Jun 30, 2024 32.81 Mn
Mar 31, 2024 156.27 Mn
Dec 31, 2023 46.85 Mn
Sep 30, 2023 49.80 Mn
Jun 30, 2023 46.31 Mn
Mar 31, 2023 49.48 Mn
Dec 31, 2022 46.22 Mn
Sep 30, 2022 9.63 Mn
Jun 30, 2022 10.30 Mn
Mar 31, 2022 25.82 Mn
Dec 31, 2021 8.94 Mn
Sep 30, 2021 21.34 Mn
Jun 30, 2021 8.93 Mn
Mar 31, 2021 86.63 Mn